A Novel Serum Based Biomarker Panel Has Complementary Ability to Preclude Presence of Early Lung Cancer for Low Dose CT (LDCT)
Oncotarget - United States
doi 10.18632/oncotarget.17477
Full Text
Open PDFAbstract
Available in full text
Categories
Date
April 27, 2017
Authors
Publisher
Impact Journals, LLC